Physician profile
Igor Ugorec
NPI 1790875961
$2,781.68
in general payments reported to CMS, 2019-2025
6 companies · $22.47 in 2025
The $22.47 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.52 · 2020: $2,434 · 2023: $34.00 · 2024: $195 · 2025: $22.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $251.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,400.00 | 2020 | |
| Ucb, INC. | $225.07 | 2019-2025 | Briviact, Nayzilam |
| Astrazeneca Pharmaceuticals LP | $54.77 | 2023-2024 | Andexxa |
| Portola Pharmaceuticals, LLC | $44.44 | 2019-2020 | |
| Arkis Biosciences INC | $41.10 | 2019 | |
| Merz North America, INC. | $16.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Igor Ugorec listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.